Where Quest Diagnostics Stands With Analysts
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent…
Citigroup Downgrades Quest Diagnostics to Sell, Lowers Price Target to $125
Citigroup analyst Patrick Donnelly downgrades Quest Diagnostics (NYSE:DGX) from Neutral to Sell and lowers the price target from $145 to $125.
‘Quest Diagnostics Completes Leadership Succession As Jim Davis Becomes CEO And President, Joins Board Of Directors’
Quest Diagnostics Completes Leadership Succession as Jim Davis Becomes CEO and President, Joins Board of Directors (accesswire.com)
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic
Morgan Stanley Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $146
Morgan Stanley analyst Ricky Goldwasser maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $142 to $146.
A Preview Of Quest Diagnostics’s Earnings
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2022-10-20. Here's what investors need to know before the announcement.
Analysts estimate that Quest Diagnostics will report an earnings per share (EPS) of $2.17.
What Fast Food And Entertainment Giants Did Traders Pick For CNBC’s Fast Money Call Of The Day
CNBC’s "Fast Money Halftime Report" delivers market-moving news to investors.
The commentary delivered by hosts of the show often moves the stocks mentioned. The information is collected and refined using Benzinga Pro’s News Tool, which can be accessed on any workstation.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
